Literature DB >> 1608903

Effect of an acute dose of alcohol on the pharmacokinetics of oral nifedipine in humans.

S Qureshi1, S Laganière, G Caillé, D Gossard, Y Lacasse, I McGilveray.   

Abstract

Pharmacokinetic and pharmacodynamic interactions of alcohol and nifedipine were assessed in 10 healthy human volunteers. Doses of 20 mg (2 x 10-mg capsules) of nifedipine were administered with either 150 ml of orange juice or 75 ml of alcohol (94%) in 75 ml of orange juice according to a crossover randomized design. Plasma nifedipine levels were monitored for 16 hr after each dosing, along with pulse rate and blood pressure. The relative bioavailability of nifedipine, measured as AUC, was increased by 54% (533 vs 346 ng.hr/ml) after the dose of alcohol (P less than 0.0002). However, there were no significant differences between treatments in Cmax, tmax, or t1/2. Although there was no difference in the systolic and diastolic blood pressure and pulse rate between the two treatment groups, the time to reach peak heart rate was significantly faster in the group treated with alcohol (1.4 vs 2.2 hr). This study shows that ethanol increases the bioavailability of nifedipine and decreases the time for onset of increased heart rate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1608903     DOI: 10.1023/a:1015866530212

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Interaction of ethanol, quinidine, and sparteine with the metabolism of nifedipine by Cunninghamella echinulata.

Authors:  B C Foster; D L Wilson; I J McGilveray
Journal:  Biopharm Drug Dispos       Date:  1990-11       Impact factor: 1.627

2.  Interaction of citrus juices with felodipine and nifedipine.

Authors:  D G Bailey; J D Spence; C Munoz; J M Arnold
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

3.  Drug-alcohol interactions.

Authors:  T G Saxe
Journal:  Am Fam Physician       Date:  1986-04       Impact factor: 3.292

Review 4.  Drug interactions with the calcium-entry blockers.

Authors:  R W Piepho; V L Culbertson; R S Rhodes
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

Review 5.  Effects of ethanol on drug and metabolite pharmacokinetics.

Authors:  E A Lane; S Guthrie; M Linnoila
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

6.  Single dose pharmacokinetics of calcium antagonist nifedipine in ethanol dependent rats.

Authors:  D Siembab; P K Janicki
Journal:  Pol J Pharmacol Pharm       Date:  1989 May-Jun

7.  Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat.

Authors:  K M Boje; H L Fung
Journal:  J Pharmacol Exp Ther       Date:  1989-05       Impact factor: 4.030

8.  Nifedipine: kinetics and dynamics in healthy subjects.

Authors:  C H Kleinbloesem; P van Brummelen; J A van de Linde; P J Voogd; D D Breimer
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

9.  Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.

Authors:  T S Foster; S R Hamann; V R Richards; P J Bryant; D A Graves; R G McAllister
Journal:  J Clin Pharmacol       Date:  1983-04       Impact factor: 3.126

10.  Pharmacokinetics and metabolism of nifedipine.

Authors:  K D Raemsch; J Sommer
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

View more
  3 in total

Review 1.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

Review 2.  The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.

Authors:  J S Grundy; R T Foster
Journal:  Clin Pharmacokinet       Date:  1996-01       Impact factor: 6.447

3.  Lack of presystemic metabolism of nifedipine in the rabbit.

Authors:  P du Souich; L Héroux; H Maurice; M Dépôt; G Caillé
Journal:  J Pharmacokinet Biopharm       Date:  1995-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.